![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » PAREXEL ACQUIRES SOUTH AFRICAN PHARMA FIRM FOR $6M
PAREXEL ACQUIRES SOUTH AFRICAN PHARMA FIRM FOR $6M
July 22, 2005
Biopharmaceutical outsourcing company Parexel International Corp. has acquired a South African pharmacology business for $6 million in cash and additional payments based on future performance. The Waltham company (Nasdaq: PRXL) said it is buying QdotPharma, a company that conducts clinical trials with special therapeutic expertise focused on drugs treating metabolic, cardiovascular, psychiatric and central nervous system disorders. Boston Business Journal (http://www.bizjournals.com/boston/stories/2005/07/18/daily46.html?from_rss=1)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct